It's a good 4c, this is playing out accordingly, onboarding should take longer than expected.Looking at the operation costs rising with revenue may mean that once the operation cost reach peak there's going to be an explosive rise in revenue, for me this is good cause want to make a lot of money all at once rather than making small money everyday.
Startups have either the option of gaining value while losing money or chase little profit over time, at the rate of revenue, CF+ should be September this year or December, unless if they do another acquisition to maximize on gaining more clients, Limepay was worth the acquisition, we now know how much they cost a month, right now acquiring a logistics company that uses blockchain would be great so that in future we profit from movement of goods, instead of relying on extend companies, unless if the R&D done by FSCO on asset tagging is our trump card then that means we are also involved in movement of goods using new digital technologies.This is starting to look exactly like a 10billion dollar company that no one has heard of.
Two years ago a lot of companies claimed they had the technology only to see them disappear, my concern is how we are going to penetrate the South American market, and Africa since Mastercard is buying up a lot of potential companies in those regions, unless the agreement we have with them will benefit us.We are not CF+ yet but I'm happy with the progress
- Forums
- ASX - By Stock
- SPX
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
SPX
spenda limited
Add to My Watchlist
9.09%
!
0.6¢

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-22
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.6¢ |
Change
0.001(9.09%) |
Mkt cap ! $27.69M |
Open | High | Low | Value | Volume |
0.6¢ | 0.7¢ | 0.6¢ | $23.32K | 3.880M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 280696 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 18216262 | 29 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 280696 | 0.006 |
51 | 24939523 | 0.005 |
8 | 15700000 | 0.004 |
9 | 26100000 | 0.003 |
5 | 17000002 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 18124441 | 28 |
0.008 | 4141717 | 24 |
0.009 | 11710538 | 17 |
0.010 | 846836 | 6 |
0.011 | 527004 | 4 |
Last trade - 15.59pm 27/06/2025 (20 minute delay) ? |
Featured News
SPX (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online